Abstract-During the development of an atherosclerotic plaque, mononuclear leukocytes infiltrate the artery wall through vascular endothelial cells (ECs). At the same time, arterial smooth muscle cells (SMCs) change from the physiological contractile phenotype to the secretory phenotype and migrate into the plaque. We investigated whether secretory SMCs released cytokines that stimulated ECs in a manner leading to increased leukocyte recruitment and thus might accelerate atheroma formation. SMCs and ECs were established in coculture on the opposite sides of a porous membrane, and the cocultured cells were incorporated into a flow-based assay for studying leukocyte adhesion. We found that coculture primed ECs so that their response to the inflammatory cytokine tumor necrosis factor-␣ was amplified. ECs cocultured with SMCs supported greatly increased adhesion of flowing leukocytes and were sensitized to respond to tumor necrosis factor-␣ at concentrations 10 000 times lower than ECs cultured alone. In addition, coculture altered the endothelial selectin adhesion molecules used for leukocyte capture. EC priming was attributable to the cytokine transforming growth factor-␤ 1 , which was proteolytically activated to a biologically active form by the serine protease plasmin. These results suggest a new role for secretory SMCs in the development of atheromatous plaque. We propose that paracrine interaction between ECs and SMCs has the potential to amplify leukocyte recruitment to sites of atheroma and exacerbate the inflammatory processes believed to be at the heart of disease progression. (Circ Res. 2001;88:615-622.)
A therosclerotic plaque typically contains abnormal deposits of mononuclear leukocytes and secretory smooth muscle cells (SMCs). 1 Ordinarily, SMCs are confined to the medial layer of the artery wall, where, as contractile cells, their physiological role is the maintenance of mechanical structure and vascular tone. Early in the genesis of atherosclerotic plaque, medial SMCs undergo mitogenic stimulation and change phenotype, losing contractile elements and acquiring the ability to replicate and migrate within the artery wall. 2 In consequence, SMCs invade the intimal layer of the diseased artery, where they contribute to progressive arterial hyperplasia by inappropriate replication and deposition of a fibrotic connective tissue matrix. 1, 2 Intimal SMCs also acquire a well-developed rough endoplasmic reticulum and alter their secretory profile, generating several proinflammatory agents. 1, 2 We wished to examine the possibility that secretory SMCs could release agents that promote the recruitment of mononuclear leukocytes to the developing plaque.
Adhesion between leukocytes in the arterial blood and activated endothelial cells (ECs) overlying atherosclerotic plaque seems to represent the major route of entry into the artery wall for T lymphocytes and monocytes. 1 The recruitment of blood-borne leukocytes to inflamed tissue normally occurs across the ECs of postcapillary venules. 3, 4 When activated by cytokines, such as tumor necrosis factor-␣ (TNF-␣), ECs express specialized adhesion receptors (E-and P-selectin and vascular cell adhesion molecule-1 [VCAM-1]), which have rapid forward kinetics for bond formation essential for binding flowing cell. 3, 4 These molecules also support subsequent rolling adhesion, 5, 6 allowing the slow-moving leukocytes to assimilate signals from the EC-borne chemoattractants that promote immobilization and transendothelial migration via integrin adhesion receptors. 3, 4 ECs of the healthy human artery do not express selectins or VCAM-1, but their expression has been demonstrated on the ECs overlying atherosclerotic plaque. [7] [8] [9] [10] Secretory SMCs generate several agents that could promote leukocyte infiltration of the artery wall. 1, 2, 11 They release potent leukocyte chemoattractants, such as interleukin-8 (IL-8) and monocyte chemotactic protein-1 (MCP-1). 12 They also release the proinflammatory cytokines TNF-␣ 13 and IL-1, 14 which induce the expression of adhesion molecules and leukocyte chemoattractants on ECs. 3, 4 The cytokine transforming growth factor-␤ 1 (TGF-␤ 1 ) is also generated in biologically active form when SMCs and ECs are cultured together. 15, 16 Although TGF-␤ 1 does not induce leukocyte adhesion to ECs in a manner comparable to TNF or IL-1, it can modulate the effects of other proinflammatory agents. 17, 18 The ability of TGF-␤ 1 to either inhibit 19 -21 or promote 22, 23 leukocyte adhesion to ECs has been reported depending on the type and conditions of growth of the ECs.
In the present study, we have developed an in vitro model of the artery wall to investigate interactions between secretory SMCs, endothelial cells, and flowing purified leukocytes in a physical milieu resembling the circulation. 3, 4 Our studies show that secretory SMCs can greatly potentiate adhesion of leukocytes to ECs. The results suggest a new role for SMCs in the cellular pathology of atherosclerosis.
Materials and Methods

Leukocyte Isolation
Mononuclear leukocytes (29% monocytes and 71% lymphocytes), purified monocytes (91% monocytes and 9% lymphocytes), peripheral blood lymphocytes (PBLs) (95% lymphocytes and 5% monocytes), and purified neutrophils (Ͼ95% granulocytes) were prepared from EDTA anticoagulated blood by density gradient centrifugation, 24 cell panning, or magnetic bead separation (for more information, see the online data supplement available at http://www.circresaha.org). To aid visualization, leukocytes were loaded with the fluorochrome calcein-AM (5 g/mL), which did not affect adhesion. 25 
Primary Culture of ECs, SMCs, and Fibroblasts
Human ECs were isolated from the veins of umbilical cords, as described elsewhere. 24, 26, 27 Each experiment used first-passage ECs from a different donor. Human SMCs were explanted from the arteries of umbilical cords. SMCs from 8 different donors were used. Skin fibroblasts were explanted from normal human foreskin. For details, see the online data supplement.
ECs and SMCs Coculture on Porous Inserts
SMCs were cultured for 24 hours on the inside of culture inserts (Becton Dickinson). ECs were then added to the outside face of the membrane and cultured alone or with SMCs for 24 hours. Coculture inserts or inserts bearing ECs alone were treated with TNF-␣ at 0 to 100 U/mL for an additional 24 hours before adhesion assay. See the online data supplement for details. In some experiments, inserts bearing ECs were treated for 24 hours with 1 or 10 ng/mL recombinant TGF-␤ 1 before addition of TNF.
Flow Adhesion Assay
Adhesion assays were conducted in a novel parallel-plate flow chamber engineered to incorporate the insert and allow perfusion of leukocytes over the ECs on the outer face of the culture membrane at 37°C. The chamber was placed on the stage of a fluorescence microscope and connected to a withdrawal syringe pump. Fluorescently labeled leukocytes were perfused over the ECs at a wall shear stress of 0.05 or 0.1 Pa, and adhesion was assessed by fluorescence microscopy. See the online data supplement for details.
Antibodies and Inhibitors
ECs or mononuclear leukocytes were treated with monoclonal adhesion-blocking antibody (mAb) against E-selectin, P-selectin, VCAM-1, or ␣ 4 integrin for 15 minutes before adhesion assay. See the online data supplement for details. TGF-␤ 1 (100 g/mL) function neutralizing antibody or control antibody or inhibitors of plasmin activity aprotinin, used at 50 g/mL, or ␣ 2 -antiplasmin, used at 2.5 g/mL, (both from Sigma) were added at the start of EC/SMC coculture.
An expanded Materials and Methods section can be found in an online data supplement available at http://www.circresaha.org.
Results
Secretory Smooth Muscle Cells Prime but Do Not Activate Cocultured Endothelial Cells for Leukocyte Adhesion
When ECs and secretory SMCs were cultured on the opposite sides of porous culture membranes for 48 hours, the ECs barely supported the adhesion of isolated mononuclear leukocytes from flow ( Figure 1 ). The level of binding to cocultured ECs was no greater than for ECs cultured alone. Thus, secretory SMCs did not activate endothelial cells.
In contrast, cocultured ECs markedly altered their response to the cytokine TNF-␣. When ECs were treated alone with TNF-␣ for 24 hours at concentrations between 0 and 100 U/mL, a dose-dependent increase in their ability to capture mononuclear leukocytes from flow between 1 and 100 U/mL was observed (Figure 1) . A qualitatively similar response to TNF-␣ was observed on endothelial cells cocultured with SMCs ( Figure 1) . However, the presence of SMCs greatly sensitized the ECs for response to TNF-␣. Significant adhesion of leukocytes was inducible with a concentration of TNF-␣ as low as 0.0001 U/mL on cocultured ECs, whereas the response of ECs alone was extinct below 1 U/mL TNF ( Figure 1 ). With TNF-␣ at or above 1 U/mL, ECs cocultured with SMCs supported levels of mononuclear cell adhesion between 100% and 200% higher than ECs cultured alone (Figure 1 ). Inserts were then treated for 24 hours with TNF-␣ over a range of concentrations (0 to 100 U/mL). Culture inserts were incorporated into a flow chamber, and the adhesion of flowing purified mononuclear cells was assessed. ANCOVA showed a significant effect of coculture (PϽ0.01) and a significant effect of TNF-␣ concentration (PϽ0.01) on the number of leukocytes adhering to ECs from flow. ECs cultured alone demonstrated a significant increase in leukocyte adhesion at 1, 10, or 100 U/mL of TNF-␣, whereas ECs cocultured with SMCs demonstrated a significant increase in leukocyte adhesion at every concentration of TNF-␣ (ϩPϽ0.05; ϩϩPϽ0.01 compared with untreated EC control by Student's paired t test). At every dose of TNF-␣ except 0.0001 U/mL, adhesion to cocultured ECs was significantly greater than to ECs alone (*PϽ0.05; **PϽ0.01 by Student's paired t test).
Secretory SMCs Prime Cocultured ECs for Enhanced Adhesion of Purified Neutrophils, Monocytes, and Peripheral Blood Lymphocytes
When ECs were cocultured with SMCs and then treated with either 0.1 or 100 U/mL TNF, the adhesion of purified neutrophils, monocytes, or PBL was increased compared with adhesion on ECs cultured alone ( Figure 2 ). As was the case for the mixed mononuclear cell preparation, adhesion to ECs cultured alone was negligible with 0.1 U/mL TNF, whereas adhesion of all cell types could be readily observed for ECs cocultured with SMCs and 0.1 U/mL TNF. At 100 U/mL TNF, there was an Ϸ2-fold increase in monocyte and neutrophil adhesion and a 3-fold increase in lymphocyte adhesion for cocultured ECs compared with ECs cultured alone. Thus, the increase in adhesion observed in mixed populations of mononuclear cells was not attributable solely to the recruitment of a particular leukocyte subset.
Contractile SMCs or Skin Fibroblasts Do Not Prime Cocultured ECs
We cocultured ECs with contractile SMCs to determine whether SMCs in their physiological phenotype had any priming effect. To culture contractile SMCs, they must be maintained in medium devoid of growth factors and containing only 0.5% serum. ECs cannot ordinarily be maintained under this regimen and have been reported to undergo apoptosis on exposure to TNF after serum-free culture. 28 In only 1 of 4 experiments did ECs maintain a monolayer suitable for adhesion studies. When cultured with contractile SMCs and 0.1 or 100 U/mL TNF, ECs showed no priming in that experiment (data not shown). In the other 3 experiments, Ͼ50% of ECs detached from the coculture inserts and attached cells had rounded up.
To ensure that EC priming was not a characteristic of all stromal cells, we cocultured skin fibroblasts with ECs. In the presence of 0.1 or 100 U/mL TNF, ECs cocultured with skin fibroblasts showed no increase in the ability to bind flowing purified PBL compared with ECs cultured alone ( Figure 3) . Thus, although secretory SMCs could prime ECs for sensitized responses to TNF, this was not a characteristic of all stromal cells.
Coculture of ECs With SMCs Alters the Patterns of EC Adhesion Molecules Used to Recruit Flowing Mononuclear Cells
We used a panel of function-blocking antibodies to investigate the roles of the endothelial receptors E-selectin, P-selectin, and VCAM-1 and the leukocyte integrin ␣ 4 ␤ 1 integrin (ligand for VCAM-1) in adhesion observed in our model. In studies on ECs cultured alone and stimulated with 100 U/mL TNF-␣, antibodies against P-selectin, VCAM-1, or ␣ 4 integrin inhibited leukocyte attachment by Ϸ50% whereas antibody against E-selectin had no significant effect ( Figure  4a ). Antibodies against ␣ 4 integrin and P-selectin had an additive effect and blocked Ͼ80% of adhesion (Figure 4a ). ECs were grown on the porous membranes of culture inserts in isolation (open bars) or in the presence of SMCs grown on the opposite face (filled bars) for 24 hours. Inserts were then treated for 24 hours with 0, 0.1, or 100 U/mL TNF. Culture inserts were incorporated into a flow chamber, and the adhesion of flowing purified neutrophils (a), purified monocytes (b), or purified PBLs (c) was assessed. ECs cultured alone demonstrated a significant increase in leukocyte adhesion at 100 U/mL of TNF-␣, whereas ECs cocultured with SMCs demonstrated a significant increase in leukocyte adhesion at both concentrations of TNF-␣ (*PϽ0.05; **PϽ0.01 compared with untreated EC control by Student's paired t test). At both doses of TNF, adhesion to cocultured ECs was significantly greater than to ECs alone (ϩPϽ0.05 by Student's paired t test). 
Thus, mononuclear leukocytes used a combination of VCAM-1 and P-selectin to bind to ECs cultured alone.
A different pattern was seen when ECs were cocultured with SMCs. When cocultured ECs were stimulated with 100 U/mL TNF-␣, antibodies against E-selectin, VCAM-1, or ␣ 4 integrin inhibited Ϸ50% of adhesion. Combination of antibodies against ␣ 4 integrin and E-selectin blocked Ͼ90% of adhesion (Figure 4b ). Antibody against P-selectin had no effect. Thus, VCAM-1 provided a common route for leukocyte adhesion under both culture regimes, but EC/SMC coculture altered the pattern of selectin adhesion molecules used for leukocyte adhesion. We determined whether the same adhesive mechanisms were functional in cocultures at lower concentrations of TNF-␣. Using 0.1 U/mL TNF-␣ (a concentration that was stimulatory for ECs only when cocultured with SMCs), leukocytes used the same combination of receptors, ie, VCAM-1 and E-selectin (Figure 4c ) as with 100 U/mL TNF-␣. Antibody studies also showed that purified monocytes and PBL both used VCAM-1 and P-selectin on ECs cultured alone but VCAM-1 and E-selectin on cocultured ECs (data not shown) (see the online data supplement for details). Thus, in coculture, both E-selectin and VCAM-1 supported adhesion at TNF-␣ concentrations, where they were not functional on ECs cultured alone.
Immunofluorescence labeling of ECs with antibodies against E-selectin or VCAM-1 and flow cytometry demonstrated that E-selectin and VCAM-1 expression were significantly increased on cocultured ECs compared with ECs cultured alone when both were stimulated with 100 U/mL (data not shown) (see the online data supplement for details). This strongly indicated that increased expression of EC adhesion receptors contributed to the adhesion of leukocytes to primed ECs.
Endothelial Cell Priming Is Dependent on Proteolytically Activated TGF-␤ 1
Modulation of EC responses to TNF has been observed by some laboratories using recombinant, biologically active TGF-␤ 1 . 19 -23 To investigate whether TGF-␤ 1 primed ECs in our model, we used a TGF-␤ 1 function neutralizing antibody in cocultures of ECs and SMCs. The antibody greatly inhibited increases in adhesion in cocultures exposed to TNF-␣ ( Figure 5 ). Adhesion to ECs cocultured in the presence of 0.1 U/mL TNF was nearly abolished (Figure 5a ), whereas the adhesion to ECs cocultured in the presence of 100 U/mL TNF was reduced to the level seen on ECs cultured alone (Figure 5b ).
TGF-␤ 1 is secreted in a biologically inert form bound to latency-associated peptide. Biologically active TGF-␤ 1 is released from this complex by an acid environment or by proteolytic cleavage. 17, 18 The serine protease plasmin, derived from plasminogen, processes TGF-␤ 1 from the inert to the biologically active form in cocultures of ECs with pericytes or with SMCs. 16 When we added the serine protease inhibitor aprotinin or the plasmin inhibitor ␣ 2 -antiplasmin to cocultures, EC priming was completely inhibited ( Figure 5) . Thus, at 0.1 U/mL TNF, the adhesion of mononuclear cells to cocultured ECs was virtually abolished by both agents (Figure 5a ). In the presence of 100 U/mL TNF, mononuclear cell adhesion to cocultured ECs was reduced nearly to the levels seen on ECs alone (Figure 5b) .
To confirm that ECs could be primed in coculture by TGF-␤ 1 , we inhibited endogenous plasmin activity (and thus the activation of endogenous TGF-␤ 1 ) with ␣ 2 -antiplasmin but also added biologically active recombinant TGF-␤ 1 . Recombinant TGF-␤ 1 reconstituted priming of cocultured ECs in a dose-dependent manner (Figure 6 ). In the presence Figure 4 . Effect of antibodies against adhesion molecules on adhesion of mononuclear cells to ECs. Leukocytes were treated with function-blocking mAb against ␣ 4 integrin, or ECs were treated with mAb against VCAM-1, E-selectin, or P-selectin, and adhesion of mononuclear cells was measured for ECs alone treated with 100 U/mL TNF-␣ (a), EC/SMC cocultures treated with 100 U/mL TNF-␣ (b), or EC/SMC cocultures treated with 0.1 U/mL TNF-␣ (c). Antibody blockade demonstrated that mononuclear leukocytes used a combination of VCAM-1 and P-selectin to bind to EC monocultures but used VCAM-1 and E-selectin to adhere to EC/SMC cocultures. **PϽ0.01 for leukocyte adhesion to EC control compared with EC/SMC control by Student's paired t test. ϩPϽ0.05; ϩϩPϽ0.01 for leukocyte adhesion in the presence of adhesion-blocking antibodies compared with adhesion without antibodies by Student's paired t test.
of 0.1 U/mL TNF (Figure 6a ) or 100 U/mL TNF (Figure 6b ), ␣ 2 -antiplasmin reduced the level of mononuclear cell adhesion to cocultured ECs to the levels seen on ECs cultured alone. When ␣ 2 -antiplasmin and 1 ng/mL of recombinant TGF-␤ 1 were simultaneously added to the cocultures, EC priming was partially restored and adhesion was higher than on ECs cultured alone (Figures 6a and 6b ). The addition of ␣ 2 -antiplasmin and 10 ng/mL recombinant TGF-␤ 1 fully restored EC priming, and mononuclear cell adhesion was equivalent to that on EC/SMC cocultures (Figures 6a and 6b) .
Recombinant TGF-␤ 1 Can Prime ECs in the Absence of Secretory SMCs
We conducted a series of experiments to determine if recombinant TGF-␤ 1 could prime ECs cultured alone for increased levels of leukocyte adhesion. ECs were cultured for 24 hours on inserts in the absence of SMCs but in the presence of recombinant TGF-␤ 1 at concentrations of 1 or 10 ng/mL. TGF-␤ 1 dose-dependently primed ECs for increased adhesion of purified flowing mononuclear cells in response to stimulation with TNF at 100 U/mL (Figure 7) . ECs also responded to TNF at 0.1 U/mL after priming with 1 ng/mL recombinant TGF-␤ 1 . ECs bound 36Ϯ3 compared with 2Ϯ0.4 leukocytes on primed and unprimed ECs, respectively (meanϮSEM of 3 matched experiments; PϽ0.05 by Student's paired t test).
In separate experiments, we cultured ECs in microtiter plates in the presence of TGF-␤ 1 . ECs cultured with 1 or 10 Effect of recombinant TGF-␤ 1 on adhesion of purified mononuclear leukocytes to ECs treated with TNF-␣. ECs were grown alone on the porous membranes of culture inserts for 24 hours. Inserts were then treated for 24 hours with 0, 1, or 10 ng/mL recombinant TGF-␣ followed by 24 hours of stimulation with 0 or 100 U/mL TNF. Culture inserts were incorporated into a flow chamber, and the adhesion of flowing mononuclear cells was assessed. Untreated ECs did not support the adhesion of leukocytes. ECs treated with 100 U/mL TNF supported significantly increased leukocyte adhesion (**PϽ0.01 compared with untreated EC control by Student's paired t test). Leukocyte adhesion was significantly increased in a dose-dependent manner when the ECs had been pretreated with 1 or 10 ng/mL TGF-␣ 1 (ϩPϽ0.05 by Student's paired t test).
ng/mL TGF-␤ 1 demonstrated increased expression of both VCAM-1 and E-selectin after stimulation with TNF at 100 or 0.1 U/mL (Figure 8 ).
Discussion
Using a novel, multicellular, flow-based model of the artery wall, we demonstrated a paracrine interaction between ECs and secretory SMCs, which may influence the progression of atherosclerosis. ECs cultured with secretory SMCs were primed for increased responsiveness to the inflammatory cytokine TNF-␣. At equal concentrations of TNF-␣, ECs cocultured with SMCs supported greatly increased adhesion of flowing leukocytes compared with ECs cultured alone. Cocultures were also sensitized to respond to much lower concentrations of TNF-␣. In addition, coculture of ECs with SMCs altered the selectin adhesion molecules used by leukocytes to bind to ECs. ECs were primed by the cytokine TGF-␤ 1 , which was enzymatically processed from an inert to biologically active form by the serine protease plasmin in coculture.
The present study improves our understanding of how interactions between cells of the artery wall may promote recruitment of leukocytes to developing atheroma. During inflammation, leukocytes adhere to selectins or VCAM-1 expressed by cytokine-stimulated ECs of postcapillary venules and migrate under the action of local chemoattractants. 3, 4 Leukocytes do not usually adhere to the wall of healthy arteries, but monocytes and T lymphocytes are found in atherosclerotic plaque. 1 Studies using animal models or human tissue have revealed the cellular composition of plaque and the local patterns of expression of adhesion molecules and chemoattractants. [7] [8] [9] [10] [11] However, in these systems, it is difficult to dissect the complex interactions between cellular components and cytokines leading to leukocyte recruitment. To overcome these limitations, we developed an in vitro model incorporating chosen cellular elements of the atherosclerotic lesion. Flow was included both to mimic the in vivo requirement for fast-acting capture receptors (selectins or VCAM-1) and enable washout of secreted chemotactic agents that may otherwise accumulate in static systems. Thus, we identified a novel pattern of adhesion molecule usage on human umbilical vein ECs (HUVECs) responding to TNF-␣ in the presence of SMCs.
Ordinarily, E-selectin expression on HUVECs peaks after 4 hours and is absent after 24 hours of exposure to TNF-␣. 29, 30 In the present study, E-selectin was functional after 24 hours on ECs cocultured with SMCs, whereas P-selectin was functional on ECs cultured alone. VCAM-1 was functional for either type of culture stimulated with TNF-␣. A switch from P-selectin to E-selectin could influence the leukocytes found in atherosclerotic plaque, for example, because the ability to use P-or E-selectin differs between subsets of T lymphocytes. 31 We have not described the intracellular mechanisms that underlie prolonged E-selectin expression. Others, using dermal microvascular ECs that demonstrate prolonged expression of E-selectin in response to TNF, 32 have described a role for sustained activity of nuclear factor-B (NF-B), the nuclear factor responsible for transcriptional activity of the E-selectin gene. 29 NF-B activity was sustained by reduction of cytoplasmic levels of IB-␤, an inhibitor of NF-B function. Alterations in the membrane turnover and intracellular degradation of E-selectin protein may also contribute to prolonged E-selectin expression in dermal microvascular ECs. 33 ECs cocultured with SMCs were primed for increased adhesion of all leukocyte types tested, including neutrophils. However, neutrophils are not present in atherosclerotic plaque, even though receptors that support neutrophil capture and adhesion are known to be expressed on diseased arteries. [7] [8] [9] [10] The inability of arterial ECs to generate chemotactic stimuli, which activate neutrophils and drive migration into the artery wall, could account for the observed lack of plaque resident neutrophils. Alternatively, neutrophils may infiltrate the artery wall but undergo rapid clearance, for example, by apoptosis.
We demonstrated that EC priming was abolished by a neutralizing mAb against TGF-␤ 1 or by inhibitors of plasminmediated activation of TGF-␤ 1 . EC priming in cocultures could be reconstituted with exogenous recombinant TGF-␤ 1 when the activation of endogenous cytokine was inhibited by antiproteases. Recombinant TGF-␤ 1 also effectively primed ECs cultured in the absence of SMCs. However, TGF-␤ 1 has previously been reported to inhibit as well as prime ECs for the recruitment of leukocytes. A series of studies described TGF-␤ 1 -dependent inhibition of leukocyte adhesion to E-selectin expressed on subconfluent HUVECs. 19, 34, 35 Studies Figure 8 . Effect of recombinant TGF-␤ 1 on the expression of VCAM-1 and E-selectin on ECs treated with TNF-␣. ECs were grown in the wells of microtiter plates for 24 hours and then treated for 24 hours with 0 or 10 ng/mL recombinant TGF-␤ 1 followed by 24 hours of stimulation with 0, 0.1, or 100 U/mL TNF. ECs were fixed, and expression of VCAM-1 (a) or E-selectin (b) was assessed using ELISA. In the absence of TGF-␤ 1 , VCAM-1 was detected in the presence of 100 U/mL TNF (ϩPϽ0.05 compared with untreated EC control by Student's paired t test), whereas E-selectin was not detected at any concentration of TNF. In the presence of 10 ng/mL recombinant TGF-␤ 1 , both VCAM-1 and E-selectin were detectable at 0.1 and 100 U/mL TNF, and expression was significantly increased compared with ECs cultured in the absence of TGF-␤ 1 (*PϽ0.05 compared with ECs with out TGF-␤ 1 by Student's paired t test).
using ECs specialized for lymphocyte trafficking during immune surveillance, eg, high endothelial venule ECs 21 and dermal microvascular ECs, 13,36 also showed inhibition of leukocyte adhesion in response to TGF-␤ 1 . Alternatively, TGF-␤ 1 -mediated priming of confluent HUVECs for increased VCAM-1 expression by lipopolysaccharide has been demonstrated. 23 Also, injection of TGF-␤ 1 into the skin of rabbits greatly increased the infiltration of neutrophils in response to a secondary challenge with TNF 24 hours later. 22 Thus, we believe that TGF-␤ 1 should be considered a regulator of leukocyte adhesion, with the nature of the response depending on the phenotype of the responding ECs. From our own studies and those of others, 22, 23 we believe that in the context of inflammation, preexposure of ECs to TGF-␤ 1 can sensitize ECs to subsequent exposure to TNF.
ECs or SMCs cultured alone do not generate biologically active TGF-␤ 1 , but cocultures of these cells produce the bioactive cytokine, which has been demonstrated to influence cellular functions, such as EC proliferation and motility. 15, 16 TGF-␤ 1 is secreted in complex with a latency-associated peptide by both ECs and SMCs in monoculture. 16 Thus, additional production of latent TGF-␤ 1 is unlikely to be a prerequisite for priming in coculture. Rather, it is the proteolytic processing of the latent cytokine to a biologically active form by plasmin that occurs in coculture but not in EC and SMC monocultures. 15, 16 It is probable that plasmin is activated in EC/SMC coculture by plasminogen activator (PA), because the inclusion of a function neutralizing antibody directed against urokinase-PA inhibits the functional activation of TGF-␤ 1 in EC/SMC cocultures. 16 Both ECs and SMCs in monoculture produce PA, 16 and it is thus unlikely that TGF-␤ 1 activation requires induction of this system in coculture. Why PA is not functional in EC and SMC monocultures is not clear, but alterations in the expression of receptors required to colocalize plasminogen and PA to the cell surface where plasmin activation occurs or alterations in the function or production of PA-inhibitor have been postulated. 15, 16, 37 
Conclusions
Our results suggest a new role for secretory SMCs in the development of atheromatous plaque. SMCs contribute to arterial thickening by invading the intima and depositing a fibrotic connective tissue matrix. 1,2 They have not previously been directly implicated in the recruitment of inflammatory mononuclear leukocytes. These leukocytes may not normally be recruited, because arterial endothelium may be exposed only to low levels of cytokines or have low responsiveness to them. We describe a mode of paracrine interaction between ECs and SMCs whereby ECs are rendered highly sensitive to TNF-␣. The priming, attributable to TGF-␤ 1 , has the potential to amplify leukocyte recruitment to sites of established atheroma and, therefore, to exacerbate the inflammatory processes believed to be at the heart of disease progression. 2 EC priming could potentiate the inflammatory effects of cytokines generated by the cells of the lession. 2 Moreover, primed ECs would have a heightened sensitivity to cytokines released elsewhere into the systemic circulation and typically found at relatively low concentration in a range of disorders with an inflammatory component. 38 This heightened sensitivity could be an important factor in the increased risk of developing atherosclerotic occlusive disease linked with chronic infectious diseases. 39, 40 
